/
| GEL thousands | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| P&L Items | |||||
| Revenue | Register | Register | Register | 9,885 | Register |
| Adj. Operating Profit² | Register | Register | Register | 1,076 | Register |
| Adj. EBITDA² | Register | Register | Register | 1,646 | Register |
| Net Income | Register | Register | Register | 1,359 | Register |
| Margins & Profitability Ratios (%) | |||||
| Gross Profit Margin¹ | Register | Register | Register | 52.4% | Register |
| Adj. Operating Profit Margin² | Register | Register | Register | 10.9% | Register |
| Adj. EBITDA Margin² | Register | Register | Register | 16.6% | Register |
| Net Income Margin | Register | Register | Register | 13.7% | Register |
| Balance Sheet Items & Leverage | |||||
| Total Assets | Register | Register | Register | 17,316 | Register |
| Total Debt³ | Register | Register | Register | 176 | Register |
| Total Debt³ / Adj. EBITDA² | Register | Register | Register | 0.11x | Register |
| Total Equity | Register | Register | Register | 13,288 | Register |
¹ COGS restated for comparability (2021): In 2021 production depreciation of GEL 0.33m, which the company's first IFRS filing included in cost of sales, is shown under operating expenses, as in its filings from 2022 on; 2021 production payroll is not disclosed and stays in cost of sales.
² Adj. Operating Profit has been adjusted to exclude non-recurring and one-time items. Adj. EBITDA is calculated by adding back D&A expenses to the adjusted operating profit.
³ Total debt includes lease liabilities, where applicable.